Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Timing of Chemotherapy with Concomitant Chemoradiotherapy in Unresectable Stage III NSCLC
NCT00198432Phase 2Completed
- Sponsor
- IFCT
- Start
- Mar 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of cisplatin, paclitaxel and vinorelbine in non-small cell lung cancer (NSCLC) (2 arms), sponsored by IFCT. Primary endpoint: Objective Response Rate. Started Mar 2002; status: completed.
02
Drugs
cisplatinpaclitaxelvinorelbine
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00198432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00198432.